We selected the most common mutations with data available, for both AD-HSP and AR-HSP (genetic subtypes SPG4, SPG7, SPG11, and SPG15), and divided the population into pre-symptomatic (before reaching age at onset) and symptomatic (after reaching age at onset). This evidence concerns the gene ZFYVE26 and hereditary spastic paraplegia.